Yoshihisa Kodama

Yoshihisa Kodama

Auto-generated profile, based on publicly available information

Yoshihisa Kodama

Department of Radiology, Teine Keijinkai Hospital, Sapporo, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Liver Cancer
Verified
Journal Article
Open access
PDF file
MIMasafumi Ikeda
Masafumi Ikeda
YAYasuaki Arai
Yasuaki Arai
YIYoshitaka Inaba
Yoshitaka Inaba
TTToshihiro Tanaka
Toshihiro Tanaka
SSShunsuke Sugawara
Shunsuke Sugawara
MSMiyuki Sone
Miyuki Sone
Introduction: With the advent of effective systemic therapy, transarterial chemoembolization (TACE) is established as a highly effective locoregional treatment modality for carefully selected patients with hepatocellular carcinoma (HCC). This randomized controlled trial was conducted to clarify whether selective TACE with drug-eluting beads (DEB-TACE) loaded with epirubicin or selective conventional TACE (cTACE) with epirubicin-ethiodized oil might be more effective for obtaining complete response(CR) in patients with HCC. Methods: Between March 2016 and May 2019, Child-Pugh class A or B patients with unresectable HCC who were scheduled to receive selective TACE were randomly assigned at a 1:1 ratio to the DEB-TACE arm or the cTACE arm. The primary endpoint was the CR rate at 3 months, as evaluated according to the modified Response Evaluation Criteria in Solid Tumors by an independent review committee, and the secondary endpoints were the CR rate at 1 month and incidences of adverse events. Results: A total of 200 patients (DEB-TACE, 99 patients; cTACE, 101 patients) were enrolled in the study. The CR rates at 3 months and 1 month were significantly higher in the cTACE arm (75.2%, 84.2%) as compared with the DEB-TACE arm (27.6%, 35.7%). However, the frequencies of adverse events of any grade, including pyrexia (DEB-TACE vs. cTACE, 19.4% vs. 45.5%, p = 0.0001), fatigue (5.1% vs. 15.8%, p = 0.0194), malaise (11.1% vs. 25.7%, p = 0.0103), appetite loss (12.1% vs. 28.7%, p = 0.0048), abdominal pain (12.1% vs. 23.8%, p = 0.0423), increased serum bilirubin (22.2% vs. 48.5%, p = 0.0002), hypoalbuminemia (43.4% vs. 60.3%, p = 0.0154), increased serum aspartate aminotransferase (35.7% vs. 81.2%, p < 0.0001), and increased serum alanine aminotransferase (35.7% vs. 77.2%, p < 0.0001), were also significantly higher in the cTACE arm than in the DEB-TACE arm. Conclusions: Selective cTACE appeared to have higher CR rates for local tumor control as compared to selective DEB-TACE for HCC. However, the frequency of postembolization syndrome was also significantly higher in the cTACE group than in the DEB-TACE group. Thus, to achieve CR, cTACE may be selected over DEB-TACE in patients who can be expected to tolerate postembolization syndrome.

3 April 2020 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
HYHajime Yamazaki
Hajime Yamazaki
STShinichi Tauchi
Shinichi Tauchi
JWJui Wang
Jui Wang
MDMitsuru Dohke
Mitsuru Dohke
NHNagisa Hanawa
Nagisa Hanawa
YYYosuke Yamamoto
Yosuke Yamamoto

4 September 2012 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
STShota Tatsumoto
Shota Tatsumoto
YKYoshihisa Kodama
Yoshihisa Kodama
YSYasuo Sakurai
Yasuo Sakurai
TSToshiya Shinohara
Toshiya Shinohara
AKAkio Katanuma
Akio Katanuma
HMHiroyuki Maguchi
Hiroyuki Maguchi

13 December 2017 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
HYHajime Yamazaki
Hajime Yamazaki
STShinichi Tauchi
Shinichi Tauchi
MKMiho Kimachi
Miho Kimachi
MDMitsuru Dohke
Mitsuru Dohke
NHNagisa Hanawa
Nagisa Hanawa
SFShingo Fukuma
Shingo Fukuma

12 November 2012 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
ATAkiko Tomonari
Akiko Tomonari
KTKunihiko Tsuji
Kunihiko Tsuji
HYHajime Yamazaki
Hajime Yamazaki
HAHironori Aoki
Hironori Aoki
JKJong‐Hon Kang
Jong‐Hon Kang
HMHiroyuki Maguchi
Hiroyuki Maguchi

3 September 2013 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
HYHajime Yamazaki
Hajime Yamazaki
KTKunihiko Tsuji
Kunihiko Tsuji
KNKazumasa Nagai
Kazumasa Nagai
ATAkiko Tomonari
Akiko Tomonari
TMTakeshi Matsui
Takeshi Matsui
HMHiroyuki Maguchi
Hiroyuki Maguchi